TLR4 and cervical carcinoma: Our study highlights a new potential pathogenetic aspect of HPV-related cervical cancer development, taking into consideration the role of TLR4 as a new diagnostic, prognostic, and potentially therapeutic biomarker, in addition to the presence of HPV.